Skip to content

A clinical trial to study effect of Ashwagandharishta and polybion syrup in early presbyacusis.

Randomized controlled clinical trial to study efficay of ashwagandharishta and polybion syrup in early presbyacusis in improving speech discrimination score.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/050141
Enrollment
44
Registered
2023-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H905- Unspecified sensorineural hearingloss

Interventions

None listed

Sponsors

Tilak Ayurveda Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having presbyacusis. Patients ready to give consent

Exclusion criteria

Exclusion criteria: Patients having history of immunosuppresant disorder. patients having perforated tympanic membrane. Patients having hearing aid.

Design outcomes

Primary

MeasureTime frame
Sample size 44 improvement in speech discrimination scoreTimepoint: 3 months

Secondary

MeasureTime frame
Sample size 44 improvement in speech discrimination scoreTimepoint: 6 months

Countries

India

Contacts

Public ContactDr Kiran Kannade

Tilak Ayurveda Mahavidyalaya

salvisangeeta@yahoo.co.in9822082795

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026